The US Supreme Court tossed Purdue Pharma LP’s $6 billion opioid settlement, nixing a deal that would have funded opioid epidemic relief efforts in exchange for protecting the company’s billionaire owners from lawsuits alleging they helped fuel the addiction crisis. …
Source: Claims Journal